Medical Market Report

Global Cancer Tumor Profiling Market By Type (Next-generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, and Others), By Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, and Research Applications), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 138188
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Cancer Tumor Profiling Market is estimated to be valued US$ XX.X million in 2019. The report on Cancer Tumor Profiling Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global cancer tumor profiling market is segmented on the basis of Type, Application, and geography.

    In 2019, the North America market is valued US$ XX.X million and the market share is estimated X.X%, and it is expected to be US$ XX.X million and X.X% in 2029, with a CAGR X.X% from 2020 to 2029.

    Cancer Tumor Profiling Market Scope:

    By type, the market is segmented into Next-generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, and Others. By Application, the market is divided into Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, and Research Application.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include QIAGEN, ROCHE MOLECULAR SYSTEMS, ABBOTT LABORATORIES, ILLUMINA, NEOGENOMICS LABORATORIES, HTG MOLECULAR DIAGNOSTIC, GENOMIC HEALTH, HOLOGIC GEN-PROBE, BD BIOSCIENCES (BECKTON DICKINSON), and SIEMENS HEALTHINEERS.

    Key Market Segments

    Type

    Next-generation Sequencing (NGS)

    Polymerase Chain Reaction (PCR)

    Immunohistochemistry (IHC)

    In Situ Hybridization (ISH)

    Microarray

    Others

    Application

    Personalized Medicine

    Diagnostics

    Biomarker Discovery

    Prognostics

    Research Application

    Key Market Players included in the report:

    QIAGEN

    ROCHE MOLECULAR SYSTEMS

    ABBOTT LABORATORIES

    ILLUMINA

    NEOGENOMICS LABORATORIES

    HTG MOLECULAR DIAGNOSTIC

    GENOMIC HEALTH

    HOLOGIC GEN-PROBE

    BD BIOSCIENCES (BECKTON DICKINSON)

    SIEMENS HEALTHINEERS

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Cancer Tumor Profiling Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Cancer Tumor Profiling Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Cancer Tumor Profiling Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Cancer Tumor Profiling Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Cancer Tumor Profiling Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Cancer Tumor Profiling Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Cancer Tumor Profiling sub-markets, depending on key regions (various vital states).
    To analyze Cancer Tumor Profiling Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Cancer Tumor Profiling Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Cancer Tumor Profiling Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Cancer Tumor Profiling Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope
    

    2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players
    

    3. Global Cancer Tumor Profiling Market Overview
    

    3.1. Cancer Tumor Profiling Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
    

      3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy
    

    4. Global Cancer Tumor Profiling Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Cancer Tumor Profiling Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Next-generation Sequencing (NGS)
    

      4.4. Polymerase Chain Reaction (PCR)
    

      4.5. Immunohistochemistry (IHC)
    

      4.6. In Situ Hybridization (ISH)
    

      4.7. Microarray
    

      4.8. Others
    

    5. Global Cancer Tumor Profiling Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Cancer Tumor Profiling Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Personalized Medicine
    

      5.4. Diagnostics
    

      5.5. Biomarker Discovery
    

      5.6. Prognostics
    

      5.7. Research Applications
    

    6. Global Cancer Tumor Profiling Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Cancer Tumor Profiling Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Cancer Tumor Profiling Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Cancer Tumor Profiling Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Cancer Tumor Profiling Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Cancer Tumor Profiling Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    

    7. Global Cancer Tumor Profiling Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. QIAGEN
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
    

      7.4. ROCHE MOLECULAR SYSTEMS
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
    

      7.5. ABBOTT LABORATORIES
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
    

      7.6. ILLUMINA
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
    

      7.7. NEOGENOMICS LABORATORIES
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
    

      7.8. HTG MOLECULAR DIAGNOSTIC
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
    

      7.9. GENOMIC HEALTH
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
    

      7.10. HOLOGIC GEN-PROBE
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments
    

      7.11. BD BIOSCIENCES (BECKTON DICKINSON)
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
    

      7.12. SIEMENS HEALTHINEERS
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.